Nifty

:

16945.05

Sensex

:

57527.10

-131.85 (-0.77%)
-398.18 (-0.69%)

Login

Nifty
Sensex

:
:

16945.05
57527.10

-131.85 (-0.77%)
-398.18 (-0.69%)

Astrazeneca Pharma India Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

74/99

BSE: 506820 | NSE: ASTRAZEN

Watchlist

NSE BSE

3358.55

24-Mar-2023

Day's Open
Day's High
Day's Low
Previous Close

3325.25
3375.00
3317.00
3338.75

Volume
Traded Value (lacs)
52 Week High
52 Week Low

4489
150.37
3620.00
2445.70

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

8,414.38
76.49
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

7,965.91
0.30%
14.69

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.51
7.13
-1.06

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
13.24
-6.52

PAT CAGR (%)

10 Years
5 Years
3 Years

-
18.91
-5.16

P:E (Median)

8 Years
5 Years
3 Years

108.36
108.75
108.83

P:BV (Average)

8 Years
5 Years
3 Years

18.73
18.73
18.78

EV:EBITDA (Average)

8 Years
5 Years
3 Years

63.96
62.01
64.00

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var%
Net Sales 249.81 200.53 24.57% 236.13 197.71 19.43% 232.33 175.40 32.46% 231.96 210.26 10.32%
Expenses 213.22 185.86 14.72% 195.40 179.79 8.68% 204.37 159.77 27.92% 194.00 169.85 14.22%
EBITDA 36.59 14.67 149.42% 40.73 17.92 127.29% 27.96 15.63 78.89% 37.96 40.41 -6.06%
EBIDTM 14.65% 7.31% 17.25% 9.06% 12.04% 8.91% 16.37% 19.22%
Other Income 7.20 5.33 35.08% 6.79 2.84 139.08% 4.11 2.90 41.72% 3.68 2.55 44.31%
Interest 0.20 0.23 -13.04% 0.16 0.25 -36.00% 0.19 0.27 -29.63% 0.21 0.28 -25.00%
Depreciation 4.13 3.51 17.66% 3.29 4.28 -23.13% 4.59 4.76 -3.57% 4.41 5.84 -24.49%
PBT 39.46 16.27 142.53% 44.07 16.24 171.37% 27.30 13.50 102.22% 37.03 36.84 0.52%
Tax 10.15 4.85 109.28% 11.50 4.29 168.07% 7.15 3.26 119.33% 9.05 9.56 -5.33%
PAT 29.30 11.42 156.57% 32.57 11.95 172.55% 20.16 10.24 96.88% 27.98 27.28 2.57%
PATM 11.73% 5.70% 13.79% 6.04% 8.68% 5.84% 12.06% 12.97%
EPS 11.72 4.57 156.46% 13.03 4.78 172.59% 8.06 4.10 96.59% 11.19 10.91 2.57%

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 950.23 805.60 813.56 831.81 728.29 571.00 543.71 563.73 517.07 473.97 390.42 Net Sales Growth 21.22% -0.98% -2.19% 14.21% 27.55% 5.02% -3.55% 9.02% 9.09% 21.40% Cost Of Goods Sold 348.92 305.28 287.30 299.97 226.73 178.21 171.18 194.81 194.23 155.08 146.54 Gross Profit 601.31 500.32 526.26 531.84 501.56 392.79 372.53 368.93 322.84 318.90 243.88 GP Margin 63.28% 62.11% 64.69% 63.94% 68.87% 68.79% 68.52% 65.44% 62.44% 67.28% 62.47% Total Expenditure 806.99 719.42 678.09 711.11 656.99 524.71 506.77 547.31 528.48 486.94 458.88 Power & Fuel Cost - 8.10 7.37 7.72 8.27 8.30 7.68 7.43 8.51 8.69 5.82 % Of Sales - 1.01% 0.91% 0.93% 1.14% 1.45% 1.41% 1.32% 1.65% 1.83% 1.49% Employee Cost - 230.21 219.54 216.70 197.40 150.39 162.04 169.35 159.84 160.46 148.46 % Of Sales - 28.58% 26.99% 26.05% 27.10% 26.34% 29.80% 30.04% 30.91% 33.85% 38.03% Manufacturing Exp. - 57.12 49.32 40.81 49.58 50.67 36.40 25.82 17.69 35.93 38.26 % Of Sales - 7.09% 6.06% 4.91% 6.81% 8.87% 6.69% 4.58% 3.42% 7.58% 9.80% General & Admin Exp. - 40.04 40.69 65.54 74.09 46.49 55.04 59.10 63.77 66.68 63.95 % Of Sales - 4.97% 5.00% 7.88% 10.17% 8.14% 10.12% 10.48% 12.33% 14.07% 16.38% Selling & Distn. Exp. - 62.09 55.94 65.13 88.18 81.07 62.56 84.65 77.77 55.54 50.72 % Of Sales - 7.71% 6.88% 7.83% 12.11% 14.20% 11.51% 15.02% 15.04% 11.72% 12.99% Miscellaneous Exp. - 16.58 17.93 15.24 12.74 9.58 11.87 6.16 6.67 4.58 50.72 % Of Sales - 2.06% 2.20% 1.83% 1.75% 1.68% 2.18% 1.09% 1.29% 0.97% 1.31% EBITDA 143.24 86.18 135.47 120.70 71.30 46.29 36.94 16.42 -11.41 -12.97 -68.46 EBITDA Margin 15.07% 10.70% 16.65% 14.51% 9.79% 8.11% 6.79% 2.91% -2.21% -2.74% -17.53% Other Income 21.78 14.76 12.84 12.99 16.29 12.25 14.39 6.77 5.85 9.21 10.46 Interest 0.76 0.95 1.09 1.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Depreciation 16.42 16.95 20.13 18.58 14.92 14.74 15.83 17.43 15.28 10.12 12.28 PBT 147.86 83.04 127.09 113.97 72.67 43.80 35.50 5.76 -20.84 -13.89 -70.27 Tax 37.85 21.44 33.79 41.76 18.22 17.89 15.45 0.50 0.00 0.51 19.26 Tax Rate 25.60% 25.82% 26.59% 36.64% 25.07% 40.84% 43.52% 8.68% 0.00% 0.00% -27.41% PAT 110.01 61.60 93.30 72.21 54.45 25.91 20.05 5.26 -20.84 -0.51 -89.53 PAT before Minority Interest 110.01 61.60 93.30 72.21 54.45 25.91 20.05 5.26 -20.84 -0.51 -89.53 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.58% 7.65% 11.47% 8.68% 7.48% 4.54% 3.69% 0.93% -4.03% -0.11% -22.93% PAT Growth 80.67% -33.98% 29.21% 32.62% 110.15% 29.23% 281.18% - - - EPS 44.00 24.64 37.32 28.88 21.78 10.36 8.02 2.10 -8.34 -0.20 -35.81

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 511.39 456.17 364.44 300.80 246.93 222.87 156.01 150.76 171.60 99.75 Share Capital 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 Total Reserves 504.44 449.58 357.85 293.70 239.85 216.22 151.01 145.76 166.60 94.75 Non-Current Liabilities 73.63 44.60 44.13 22.75 109.73 88.68 38.96 1.02 0.49 0.49 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 84.91 50.50 49.47 46.11 142.28 128.90 37.70 0.00 0.00 0.00 Current Liabilities 392.30 373.43 367.10 267.60 218.67 202.05 234.05 259.82 243.50 205.86 Trade Payables 188.06 178.37 209.72 168.20 127.20 87.66 94.63 111.27 109.87 90.67 Other Current Liabilities 99.48 82.58 71.06 54.38 39.41 69.84 121.08 111.60 96.50 77.21 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 104.76 112.48 86.32 45.02 52.06 44.55 18.33 36.95 37.13 37.98 Total Liabilities 977.32 874.20 775.67 591.15 575.33 513.60 429.02 411.60 415.59 306.10 Net Block 74.49 80.96 71.53 74.83 75.46 86.84 97.36 100.99 94.22 24.54 Gross Block 168.83 159.78 132.84 119.83 105.85 102.57 203.76 191.44 169.75 98.64 Accumulated Depreciation 94.34 78.82 61.31 45.00 30.39 15.73 106.40 90.46 75.53 74.11 Non Current Assets 212.00 185.51 193.49 177.81 242.69 250.34 161.95 148.33 140.96 141.29 Capital Work in Progress 2.20 4.02 24.24 6.90 3.57 4.81 6.31 12.21 9.31 73.70 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 Long Term Loans & Adv. 135.31 100.52 97.71 95.83 163.39 158.27 57.68 34.55 37.06 34.73 Other Non Current Assets 0.00 0.01 0.01 0.25 0.27 0.42 0.61 0.59 0.37 8.32 Current Assets 765.32 688.69 582.18 413.34 332.64 263.26 267.07 263.26 274.62 164.81 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 140.22 159.80 165.15 118.10 113.15 57.71 76.73 86.13 95.76 85.37 Sundry Debtors 85.89 85.19 83.21 79.75 54.63 43.00 83.14 42.77 52.93 27.96 Cash & Bank 448.46 352.35 252.52 173.30 125.92 115.58 76.83 25.08 89.07 18.47 Other Current Assets 90.75 14.05 19.85 12.94 38.94 46.97 30.37 109.27 36.87 33.01 Short Term Loans & Adv. 78.11 77.30 61.45 29.25 30.87 23.43 20.22 107.46 32.33 20.33 Net Current Assets 373.02 315.26 215.08 145.74 113.97 61.21 33.03 3.44 31.12 -41.05 Total Assets 977.32 874.20 775.67 591.15 575.33 513.60 429.02 411.59 415.58 306.10

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 100.80 104.78 87.42 54.98 8.79 38.10 56.99 -45.70 -0.81 -6.04 PBT 83.04 127.09 113.97 72.67 43.80 35.50 5.76 -20.84 0.00 -70.27 Adjustment 9.66 14.20 9.75 7.62 3.39 14.61 12.11 8.58 -10.85 2.97 Changes in Working Capital 32.89 -3.95 -2.66 9.81 -34.25 -0.24 42.09 -32.58 17.66 61.06 Cash after chg. in Working capital 125.59 137.34 121.06 90.10 12.94 49.87 59.97 -44.83 6.81 -6.24 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -24.79 -32.56 -33.64 -35.12 -4.15 -11.77 -2.98 -0.87 -7.62 0.20 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 4.74 173.03 -170.80 4.28 -9.36 0.25 -3.61 -18.64 -14.57 -15.62 Net Fixed Assets -7.23 -6.72 -30.35 -17.31 -2.04 102.69 -6.42 -24.59 -6.72 -18.43 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 Others 11.97 179.75 -140.45 21.59 -7.32 -102.44 2.81 5.95 -7.86 2.81 Cash from Financing Activity -9.46 -8.97 -6.36 0.00 0.00 0.00 -0.51 0.00 86.22 -10.33 Net Cash Inflow / Outflow 96.08 268.84 -89.74 59.26 -0.57 38.35 52.87 -64.34 70.84 -31.98 Opening Cash & Equivalents 352.34 83.50 173.24 113.98 114.55 76.20 23.33 87.68 16.83 48.81 Closing Cash & Equivalent 448.42 352.34 83.50 173.24 113.98 114.55 76.20 23.33 87.68 16.83

Financial Ratios

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 203.78 181.83 145.14 119.48 97.94 88.49 62.41 60.30 68.64 39.90 ROA 6.65% 11.31% 10.57% 9.34% 4.76% 4.25% 1.25% -5.04% -0.14% -28.28% ROE 12.78% 22.83% 21.83% 20.03% 11.12% 10.63% 3.43% -12.93% -0.38% -61.95% ROCE 17.36% 31.24% 34.61% 26.53% 18.65% 18.74% 3.76% -12.93% 0.00% -48.62% Fixed Asset Turnover 4.93 5.58 6.58 6.45 5.49 3.58 2.88 2.91 3.61 4.11 Receivable days 38.57 37.62 35.75 33.67 31.15 41.96 40.32 33.27 30.50 27.61 Inventory Days 67.64 72.59 62.15 57.95 54.51 44.72 52.15 63.23 68.29 73.50 Payable days 219.06 246.52 99.66 91.40 73.21 75.53 75.14 85.66 81.76 50.01 Cash Conversion Cycle -112.84 -136.32 -1.76 0.22 12.45 11.15 17.33 10.84 17.03 51.10 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 88.41 117.60 100.97 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Top Investors:

tejas bhalchandra trivedi

minaxi bhalchandra trivedi

shivani t. trivedi

nippon life india trustee ltd (various schemes)

investor education and protection fund (iepf)

Annual Reports:

News Update:

Astrazeneca Pharma I - Quarterly Results
10th Feb 2023, 17:22 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback